I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Incazelo emfushane:

Igama: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9

Ukubukeka: I-Crystalline Powder Emhlophe noma Engamhlophe

I-Assay: ≥99.0% (HPLC)

I-Intermediate of Clofarabine (CAS: 123318-82-1) ekwelapheni Izingane ezine-Acute Lymphoblastic Leukemia (BONKE)

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Commercial Supply Okuhlobene Okuhlobene:
I-Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
I-2,6-Dichloropurine CAS: 5451-40-1

Chemical Properties:

Igama Lekhemikhali I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Omqondofana 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Inombolo ye-CAS 6974-32-9
Inombolo yeCAT I-RF-PI222
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula C28H24O9
Isisindo samangqamuzana 504.49
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder Emhlophe noma Engamhlophe
Indlela Yokuhlola / Yokuhlaziya ≥99.0% (HPLC)
I-Melting Point 126.0~133.0℃
Ukulahlekelwa Ekumisweni ≤0.50%
Izinsalela ekushiseni ≤0.50%
Ukungcola Okuphelele ≤1.00%
Izinsimbi Ezisindayo ≤20ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Pharmaceutical Intermediate ye-Clofarabine CAS: 123318-82-1

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

12

Isicelo:

I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) iphakathi (i-Clofarabine CAS: 123318-82-1).I-Clofarabine (i-CAS: 123318-82-1) iyinoveli yemithi elwa nomdlavuza ye-purine nucleoside iqala ukuthuthukiswa ngempumelelo yi-Top10 biopharmaceutical company ye-United States-Genzyme Corporation ngamagama okuhweba athi “Clofarabine”.Ngomhla zingama-28 kuZibandlela wezi-2004 i-US Food and Drug Administration (FDA) yasebenzisa i-fast-track ukuze kuvunywe i-clofarabine ukuze isetshenziswe ezinganeni ezine-acute lymphocytic leukemia (YONKE);inomphumela omuhle kakhulu ekwelapheni i-leukemia ngokubekezelela kahle futhi akukho ukusabela okubi okungalindelekile.Ingalawulwa ngokufakwa emthanjeni noma ngokulawulwa ngomlomo.Lesi sidakamizwa siwumkhiqizo wokuqala ogunyazwe ukuthi unikezelwe ekwelapheni i-leukemia yezingane eminyakeni engaphezu kweyishumi.

Bhala umyalezo wakho lapha futhi usithumelele wona